Session 15
Translating EU pharma reform into patient access
From law to impact
Thursday, 1 October 2026 | 09:00-10:00 | Conference Centre
Organised by PHARMIG
Europe is entering a decisive phase in health policy. The revised European Union Pharmaceutical Legislation—the most significant reform in over two decades—aims to improve access, availability, and affordability of medicines while strengthening Europe’s global competitiveness.
As the legislation moves towards implementation, key questions emerge: What does improved access mean in practice? Which mechanisms and flexibilities will shape outcomes? And how will broader geopolitical dynamics—such as global pricing pressures and trade developments—affect Europe’s ability to deliver on its objectives?
This session will focus on how the new framework can translate into timely and equitable access for patients across Member States.
SPEAKERS
- Rainer Becker, Director for Medical Products and Innovation, European Commission Directorate-General for Health and Food Safety
- Stefan Eichwalder, Director of the Health Systems Division, Austrian Federal Ministry of Labour, Social Affairs, Health, Care and Consumer Protection
- Valentina Strammiello, Executive Director, European Patients' Forum
- Yannis Natsis, Director, European Social Insurance Platform
- Alexander Natz, Secretary General, EUCOPE
Further speakers to be announced
